glp-1 depression Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of | Pharmacological Reports Dulaglutide impedes depressive-like behavior persuaded

Instead, the Lancet Commission is looking to define more appropriate, scientifically sound and pragmatic criteria for the diagnosis of clinical obesity as a disease state, not a risk factor

Singh A, Sohal A, Batta A

Competing interests We have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

This regulatory distinction creates substantial patient safety concerns

Ninety-eight patients with obesity and MASH underwent liver magnetic resonance imaging and had blood biomarkers of liver injury and fibrosis measured

Future studies with larger datasets may clarify whether specific SNPs disproportionately drive observed effects or if subtle pleiotropic pathways exist